SAM
TXMD icon

Storebrand Asset Management’s TherapeuticsMD TXMD Stock Holding History

Storebrand Asset Management’s Portfolio TXMD Stock Details TXMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-57,257
Closed -$3.41M – 851
2021
Q2 		$3.41M Hold
57,257
– – 0.02% 594
2021
Q1 		$3.84M Buy
57,257
+24,000
+72% +$1.88M 0.02% 565
2020
Q4 		$2.01M Hold
33,257
– – 0.01% 632
2020
Q3 		$2.63M Buy
+33,257
New +$2.65M 0.02% 570

Other funds holding TXMD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
CWG
C WorldWide Group Copenhagen, Denmark $4.66B AUM 11.67% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Storebrand Asset Management's TXMD Position: Q3 2021 in Review

Storebrand Asset Management sold out of TherapeuticsMD (TXMD) in Q3 2021, closing a stake of 57,257 shares — an estimated $3.41M sold.

Storebrand Asset Management first reported a position in TXMD in Q3 2020 and held it in 4 quarters. The position peaked at $3.84M in Q1 2021. 149 funds tracked by Wall St. Rank hold TXMD as of Q3 2021.

  • Storebrand Asset Management reported no remaining TherapeuticsMD position as of Q3 2021 after selling out during the quarter.
  • Storebrand Asset Management sold 57,257 TherapeuticsMD shares in Q3 2021, an estimated $3.41M.
  • Storebrand Asset Management first reported a position in TherapeuticsMD in Q3 2020 and held it in 4 quarters.
  • Storebrand Asset Management's TherapeuticsMD position peaked at $3.84M in Q1 2021.
  • 149 funds tracked by Wall St. Rank held TherapeuticsMD as of Q3 2021.

Based on Storebrand Asset Management's 13F filing for Q3 2021, filed 18 Jun 2026.